XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Deficit)
Total
Beginning Balance - Shares at Mar. 31, 2022 24,486,239        
Beginning Balance - Amount at Mar. 31, 2022 $ 24 $ 53,083 $ (154) $ 11,498 $ 64,451
Issuance of common stock under employee stock option plans, shares 198,820        
Issuance of common stock under employee stock option plans, amount $ 1 401     402
Stock-based compensation expense   2,469     2,469
Comprehensive loss:          
Net loss       (15,977) (15,977)
Net unrealized gain on available-for-sale investments     27   27
Ending Balance, Shares at Mar. 31, 2023 24,685,059        
Ending Balance, Amount at Mar. 31, 2023 $ 25 55,953 (127) (4,479) 51,372
Issuance of common stock under employee stock option plans, shares 482,313        
Issuance of common stock under employee stock option plans, amount   1,654     1,654
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs, shares 133,000        
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs, amount   153     153
Stock-based compensation expense   2,838     2,838
Comprehensive loss:          
Net loss       (20,087) (20,087)
Net unrealized gain on available-for-sale investments     40   40
Ending Balance, Shares at Mar. 31, 2024 25,300,372        
Ending Balance, Amount at Mar. 31, 2024 $ 25 60,598 (87) (24,566) 35,970
Issuance of common stock under employee stock option plans, shares 305,601        
Issuance of common stock under employee stock option plans, amount $ 1 632     633
Stock-based compensation expense   2,262     2,262
Comprehensive loss:          
Net loss       (10,639) (10,639)
Ending Balance, Shares at Mar. 31, 2025 25,605,973        
Ending Balance, Amount at Mar. 31, 2025 $ 26 $ 63,492 $ (87) $ (35,205) $ 28,226